149 related articles for article (PubMed ID: 12468916)
21. Serum thrombopoietin and plasma glycocalicin concentrations as useful diagnostic markers in thrombocytopenic disorders.
Kunishima S; Tahara T; Kato T; Kobayashi S; Saito H; Naoe T
Eur J Haematol; 1996 Jul; 57(1):68-71. PubMed ID: 8698134
[TBL] [Abstract][Full Text] [Related]
22. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.
Gernsheimer TB
Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086
[TBL] [Abstract][Full Text] [Related]
23. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial.
Bussel JB; Provan D; Shamsi T; Cheng G; Psaila B; Kovaleva L; Salama A; Jenkins JM; Roychowdhury D; Mayer B; Stone N; Arning M
Lancet; 2009 Feb; 373(9664):641-8. PubMed ID: 19231632
[TBL] [Abstract][Full Text] [Related]
24. Serum levels of thrombopoietin, IL-11, and IL-6 in pediatric thrombocytopenias.
Cremer M; Schulze H; Linthorst G; Folman CC; Wehnert S; Strauss G; von dem Borne AE; Welte K; Ballmaier M
Ann Hematol; 1999 Sep; 78(9):401-7. PubMed ID: 10525827
[TBL] [Abstract][Full Text] [Related]
25. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura.
Bussel JB; Cheng G; Saleh MN; Psaila B; Kovaleva L; Meddeb B; Kloczko J; Hassani H; Mayer B; Stone NL; Arning M; Provan D; Jenkins JM
N Engl J Med; 2007 Nov; 357(22):2237-47. PubMed ID: 18046028
[TBL] [Abstract][Full Text] [Related]
26. Chronic thrombocytopenia of childhood: use of non-invasive methods in clinical evaluation.
Rajantie J; Javela K; Joutsi-Korhonen L; Kekomäki R
Eur J Haematol; 2004 Apr; 72(4):268-72. PubMed ID: 15089765
[TBL] [Abstract][Full Text] [Related]
27. Serum thrombopoietin level is mainly regulated by megakaryocyte mass rather than platelet mass in human subjects.
Nagasawa T; Hasegawa Y; Shimizu S; Kawashima Y; Nishimura S; Suzukawa K; Mukai H; Hori M; Komeno T; Kojima H; Ninomiya H; Tahara T; Abe T
Br J Haematol; 1998 May; 101(2):242-4. PubMed ID: 9609516
[TBL] [Abstract][Full Text] [Related]
28. A cost-utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP).
O'Brien SH; Ritchey AK; Smith KJ
Pediatr Blood Cancer; 2007 Feb; 48(2):173-80. PubMed ID: 16550529
[TBL] [Abstract][Full Text] [Related]
29. [The relativity study of thrombopoietin and chronic idiopathic thrombocytopenic purpura].
Liao X; Wang Y; Deng C
Zhonghua Xue Ye Xue Za Zhi; 2001 Sep; 22(9):473-5. PubMed ID: 11758228
[TBL] [Abstract][Full Text] [Related]
30. Platelet activation in Helicobacter pylori-associated idiopathic thrombocytopenic purpura: eradication reduces platelet activation but seldom improves platelet counts.
Ahn ER; Tiede MP; Jy W; Bidot CJ; Fontana V; Ahn YS
Acta Haematol; 2006; 116(1):19-24. PubMed ID: 16809885
[TBL] [Abstract][Full Text] [Related]
31. The association of oxidant status and antioxidant capacity in children with acute and chronic ITP.
Akbayram S; Doğan M; Akgün C; Mukul Y; Peker E; Bay A; Caksen H; Oner AF
J Pediatr Hematol Oncol; 2010 May; 32(4):277-81. PubMed ID: 20404751
[TBL] [Abstract][Full Text] [Related]
32. Thrombopoietin and platelet production in chronic immune thrombocytopenia.
Kuter DJ; Gernsheimer TB
Hematol Oncol Clin North Am; 2009 Dec; 23(6):1193-211. PubMed ID: 19932428
[TBL] [Abstract][Full Text] [Related]
33. Oral megadose methylprednisolone versus intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura.
Ozsoylu S; Sayli TR; Oztürk G
Pediatr Hematol Oncol; 1993; 10(4):317-21. PubMed ID: 8292515
[TBL] [Abstract][Full Text] [Related]
34. Thrombopoietin levels in patients with disorders of platelet production: diagnostic potential and utility in predicting response to TPO receptor agonists.
Makar RS; Zhukov OS; Sahud MA; Kuter DJ
Am J Hematol; 2013 Dec; 88(12):1041-4. PubMed ID: 23913253
[TBL] [Abstract][Full Text] [Related]
35. Cytokine changes in response to TPO receptor agonist treatment in primary immune thrombocytopenia.
Qu MM; Liu XN; Liu XG; Feng Q; Liu Y; Zhang X; Liu S; Zhang L; Li GS; Zhu YY; Lv MY; Peng J; Hou M
Cytokine; 2017 Apr; 92():110-117. PubMed ID: 28142109
[TBL] [Abstract][Full Text] [Related]
36. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP.
Bussel JB; Kuter DJ; George JN; McMillan R; Aledort LM; Conklin GT; Lichtin AE; Lyons RM; Nieva J; Wasser JS; Wiznitzer I; Kelly R; Chen CF; Nichol JL
N Engl J Med; 2006 Oct; 355(16):1672-81. PubMed ID: 17050891
[TBL] [Abstract][Full Text] [Related]
37. Platelet function and soluble P-selectin in patients with primary immune thrombocytopenia.
Mehic D; Machacek J; Schramm T; Buresch L; Kaider A; Eichelberger B; Haslacher H; Fillitz M; Dixer B; Flasch T; Anderle T; Rath A; Assinger A; Ay C; Pabinger I; Gebhart J
Thromb Res; 2023 Mar; 223():102-110. PubMed ID: 36738663
[TBL] [Abstract][Full Text] [Related]
38. A Case of Multiple Cerebral Infarction Preceding Acute Exacerbation of Idiopathic Thrombocytopenic Purpura.
Sasaki T; Yasuda T; Abe D; Miyano R; Kainaga M; Tomura N; Kitamura M; Nakayama T; Imafuku I
J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):789-791. PubMed ID: 30553647
[TBL] [Abstract][Full Text] [Related]
39. Effect of thrombopoietin receptor agonists on markers of coagulation and P-selectin in patients with immune thrombocytopenia.
Garabet L; Ghanima W; Monceyron Jonassen C; Skov V; Holst R; Mowinckel MC; C Hasselbalch H; A Kruse T; Thomassen M; Liebman H; Bussel JB; Sandset PM
Platelets; 2019; 30(2):206-212. PubMed ID: 29215956
[TBL] [Abstract][Full Text] [Related]
40. Serum thrombopoietin levels in relation to disease status in patients with immune thrombocytopenic purpura.
Kappers-Klunne MC; de Haan M; Struijk PC; van Vliet HH
Br J Haematol; 2001 Dec; 115(4):1004-6. PubMed ID: 11843841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
